Cell cyde kinetics of solid tumors in the past have been restricted to an in vitro labeling index (LI) measurement. Two thymidine analogues, bromodeoxyuridine (BrdU) and iododeoxyutidine (IUdR), can be used to label S-phase cells in vivo because they can be detected in situ by use of monodonal antibodies (MAb) against BrdU (Br-3) or IUdR (3D9). Patients with a variety of solid tumors (lymphoma, brain, colon cancers) received sequential intravenous IUdR and BrdU. Tumor tissue removed at the end of infusion was embedded in plastic and treated with MAb Br-3 and 3D9 sequentially, using a modification of a previously described method. Clearly single and double labeled cells were visi-
Introduction
Cell cycle kinetic studies have been conducted in a variety of solid tumors using either in vitro or in vivo labeling of S-phase cells by tritiated thymidine (3HTdr) (1,2). More recently, thymidine analogues such as bromodeoxyuridine (BrdU) and iododeoxyuridine (IUdR) have been used to label S-phase cells (3, 4) . These agents become incorporated into the newly synthesized strand of DNA of S-phase cells, and can be administered in vivo with greater ease and safety than radiolabeled compounds. For example, we have infused BrdU as an S-phase-specific label in several hundred patients with leukemias and solid tumors. Cancer cells or tumor tissue are removed at the end of the infusion and treated with a monoclonal antibody (MAb) to BrdU to detect the BrdU-labeled S-phase cells (5, 6) . 
Mass of IgG

Results
These will be described separately for the control experiments and the studies conducted in solid tumor patients. slides and 100 hr for the BrdU slide (Table  1) . Finally, the breast cancer patient who received only IUdR in vivo showed no reactivity with MAb Br-3 ( Figure  la) , whereas the brain tumor patient who received only BrdU in vivo was clearly reactive with MAb Br-3 ( Figure  ib) .
Results of Control Slides
When the Br-3 isotype mouse IgG (kappa) was used instead ofBr-3, or as a substitute for 3D9, no color development was noted in any tumor tissue even though the entire procedure was otherwise exactly the same. When the mouse IgG (kappa) was used in place ofBr-3, followed by application of 3D9, blue color was clearly present but no brown staining was noted. 
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